Venn launches innovation division for co-development

by PharmaTimes | 1st Jan 2000 | News

Tags

Related posts

NICE backs PADCEV and KEYTRUDA combination

NICE backs PADCEV and KEYTRUDA combination

Nov 11, 2026

First patient dosed in rectal cancer BT-001 trial

First patient dosed in rectal cancer BT-001 trial

Nov 10, 2026

Nxera signs $1.47bn AbbVie licensing deal

Nxera signs $1.47bn AbbVie licensing deal

Nov 10, 2026

Myeloma fund launches with £15m initial backing

Myeloma fund launches with £15m initial backing

Nov 9, 2026

PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN

E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999